SBRA (Sabra Health Care REIT) Research & Development: $0.0 Mil (TTM As of Mar. 2026)


SBRA Sabra Health Care REIT Inc SBRA
80 GF Score
Price $19.31
GF Value $19.32
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Sabra Health Care REIT Research & Development?

Sabra Health Care REIT SBRA +1.15% 80 Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus rates SBRA with a GF Score™ of 80/100 and a GF Value™ of $19.32 (Fairly Valued). The stock has 10 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sabra Health Care REIT's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

Sabra Health Care REIT  (NAS:SBRA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sabra Health Care REIT Research & Development Related Terms

Sabra Health Care REIT Research & Development Historical Data

* Premium members only.

The historical data trend for Sabra Health Care REIT's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sabra Health Care REIT Research & Development Chart

Sabra Health Care REIT Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sabra Health Care REIT Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SBRA
80GF Score
Sabra Health Care REIT Inc SBRA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sabra Health Care REIT Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Sabra Health Care REIT (SBRA) has a Research & Development of $0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Sabra Health Care REIT and its competitors.
Is Sabra Health Care REIT's Research & Development too high?
Sabra Health Care REIT's current Research & Development is $0.0 Mil. Overall, Sabra Health Care REIT has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sabra Health Care REIT's Research & Development compare to NHI and HR?
Sabra Health Care REIT's Research & Development of $0.0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sabra Health Care REIT and its competitors. Sabra Health Care REIT's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sabra Health Care REIT stock overvalued right now?
Based on GuruFocus' analysis, Sabra Health Care REIT (SBRA) is currently considered Fairly Valued. The stock's GF Value™ is $19.32, compared to a current price of $19.31 — trading 0.1% below its estimated fair value. The current Research & Development is $0.0 Mil. Sabra Health Care REIT's overall GF Score™ is 80/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sabra Health Care REIT (SBRA), the current Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sabra Health Care REIT (SBRA) Overvalued in 2026?

Based on GuruFocus' analysis, Sabra Health Care REIT stock appears to be undervalued. The current stock price of $19.31 is trading 0.1% below its estimated GF Value™ of $19.32. GuruFocus considers Sabra Health Care REIT to be Fairly Valued.

Key valuation signals for SBRA:

  • Research & Development: $0.0 Mil
  • GF Value™: $19.32 vs. price of $19.31 (0.1% below fair value)
  • GF Score™: 80/100 with 10 warning signs

No single metric tells the full story. See the SBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sabra Health Care REIT Business Description

Industry Real EstateREITs
Other Exchanges SBC:Germany
Address 1781 Flight Way, Tustin, CA, USA, 92782
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
80GF Score

Get the complete analysis for SBRA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.31
Price
$19.32
GF Value